Graham G. Walmsley bought AKRO
October 8, 2025 · Form 4 insider transaction
Graham G. Walmsley bought 13,000 shares of Akero Therapeutics, Inc. at $26.32 per share, a transaction worth $342.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,000
Price
$26.32
Total value
$342.2K
InsiderGraham G. Walmsley
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after56,168
OwnershipDirect
10b5-1 planNo
AmendedNo